p38 alpha / MAPK14 Recombinant Rabbit Monoclonal Antibody [SR43-04]
Overview
Product Name
p38 alpha / MAPK14 Recombinant Rabbit Monoclonal Antibody [SR43-04]
Antibody Type
Recombinant Rabbit monoclonal Antibody
Immunogen
Synthetic peptide within human p38 aa 160-200.
Species Reactivity
Human, Mouse, Rat
Validated Applications
WB, IF-Cell, FC
Molecular Weight
Predicted band size: 41 kDa
Positive Control
Hela cell lysate, NIH/3T3 cell lysate, PC-12 cell lysate, THP-1 cell lysate, Jurkat cell lysate, C2C12 cell lysate, rat kidney tissue lysate, mouse kidney tissue lysate, HeLa, RAW264.7, C6.
Conjugation
unconjugated
Clone Number
SR43-04
RRID
Product Features
Form
Liquid
Concentration
Storage Instructions
Shipped at 4℃. Store at +4℃ short term (1-2 weeks). It is recommended to aliquot into single-use upon delivery. Store at -20℃ long term.
Storage Buffer
1*TBS (pH7.4), 0.05% BSA, 40% Glycerol. Preservative: 0.05% Sodium Azide.
Isotype
IgG
Purification Method
Protein A affinity purified.
Application Dilution
-
WB
-
1:1,000
-
IF-Cell
-
1:100-1:500
-
FC
-
1:1,000
Target
Function
p38 mitogen-activated protein kinases are a class of mitogen-activated protein kinases (MAPKs) that are responsive to stress stimuli, such as cytokines, ultraviolet irradiation, heat shock, and osmotic shock, and are involved in cell differentiation, apoptosis and autophagy. Persistent activation of the p38 MAPK pathway in muscle satellite cells (muscle stem cells) due to ageing, impairs muscle regeneration. p38 MAP Kinase (MAPK), also called RK or CSBP (Cytokinin Specific Binding Protein), is the mammalian orthologue of the yeast Hog1p MAP kinase, which participates in a signaling cascade controlling cellular responses to cytokines and stress. Four p38 MAP kinases, p38-α (MAPK14), -β (MAPK11), -γ (MAPK12 / ERK6), and -δ (MAPK13 / SAPK4), have been identified. Similar to the SAPK/JNK pathway, p38 MAP kinase is activated by a variety of cellular stresses including osmotic shock, inflammatory cytokines, lipopolysaccharides (LPS), ultraviolet light, and growth factors. MKK3 and SEK activate p38 MAP kinase by phosphorylation at Thr-180 and Tyr-182.
Background References
1. Yan T et al. Luteolin inhibits behavioral sensitization by blocking methamphetamine-induced MAPK pathway activation in the caudate putamen in mice. PLoS One 9:e98981 (2014).
2. Pagliara V et al. Protease Nexin-1 affects the migration and invasion of C6 glioma cells through the regulation of urokinase Plasminogen Activator and Matrix Metalloproteinase-9/2. Biochim Biophys Acta 1843:2631-44 (2014).
Sequence Similarity
Belongs to the protein kinase superfamily. CMGC Ser/Thr protein kinase family. MAP kinase subfamily.
Tissue Specificity
Brain, heart, placenta, pancreas and skeletal muscle. Expressed to a lesser extent in lung, liver and kidney.
Post-translational Modification
Dually phosphorylated on Thr-180 and Tyr-182 by the MAP2Ks MAP2K3/MKK3, MAP2K4/MKK4 and MAP2K6/MKK6 in response to inflammatory citokines, environmental stress or growth factors, which activates the enzyme. Dual phosphorylation can also be mediated by TAB1-mediated autophosphorylation. TCR engagement in T-cells also leads to Tyr-323 phosphorylation by ZAP70. Dephosphorylated and inactivated by DUPS1, DUSP10 and DUSP16. PPM1D also mediates dephosphorylation and inactivation of MAPK14.; Acetylated at Lys-53 and Lys-152 by KAT2B and EP300. Acetylation at Lys-53 increases the affinity for ATP and enhances kinase activity. Lys-53 and Lys-152 are deacetylated by HDAC3.; Ubiquitinated. Ubiquitination leads to degradation by the proteasome pathway.
Subcellular Location
Cytoplasm, Nucleus.
Synonyms
CSAID Binding Protein 1 antibody
CSAID binding protein antibody
CSAID-binding protein antibody
Csaids binding protein antibody
CSBP 1 antibody
CSBP 2 antibody
CSBP antibody
CSBP1 antibody
CSBP2 antibody
CSPB1 antibody
ExpandCSAID Binding Protein 1 antibody
CSAID binding protein antibody
CSAID-binding protein antibody
Csaids binding protein antibody
CSBP 1 antibody
CSBP 2 antibody
CSBP antibody
CSBP1 antibody
CSBP2 antibody
CSPB1 antibody
Cytokine suppressive anti-inflammatory drug-binding protein antibody
EXIP antibody
MAP kinase 14 antibody
MAP kinase MXI2 antibody
MAP kinase p38 alpha antibody
MAPK 14 antibody
MAPK14 antibody
MAX interacting protein 2 antibody
MAX-interacting protein 2 antibody
Mitogen Activated Protein Kinase 14 antibody
Mitogen activated protein kinase p38 alpha antibody
Mitogen-activated protein kinase 14 antibody
Mitogen-activated protein kinase p38 alpha antibody
MK14_HUMAN antibody
Mxi 2 antibody
MXI2 antibody
p38 ALPHA antibody
p38 antibody
p38 MAP kinase antibody
p38 MAPK antibody
p38 mitogen activated protein kinase antibody
p38ALPHA antibody
p38alpha Exip antibody
PRKM14 antibody
PRKM15 antibody
RK antibody
SAPK2A antibody
CollapseImages
-
Western blot analysis of p38 alpha / MAPK14 on different lysates with Rabbit anti-p38 alpha / MAPK14 antibody (ET1602-26) at 1/1,000 dilution.
Lane 1: Hela cell lysate
Lane 2: NIH/3T3 cell lysate
Lane 3: PC-12 cell lysate
Lane 4: THP-1 cell lysate
Lane 5: Jurkat cell lysate
Lysates/proteins at 10 µg/Lane.
Predicted band size: 41 kDa
Observed band size: 38 kDa
Exposure time: 2 minutes;
12% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1602-26) at 1/1,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:300,000 dilution was used for 1 hour at room temperature. -
Western blot analysis of p38 alpha / MAPK14 on different lysates with Rabbit anti-p38 alpha / MAPK14 antibody (ET1602-26) at 1/1,000 dilution.
Lane 1: THP-1 cell lysate (10 µg/Lane)
Lane 2: C2C12 cell lysate (10 µg/Lane)
Lane 3: PC-12 cell lysate (10 µg/Lane)
Lane 4: Rat kidney tissue lysate (20 µg/Lane)
Lane 5: Mouse kidney tissue lysate (20 µg/Lane)
Predicted band size: 41 kDa
Observed band size: 38 kDa
Exposure time: 3 minutes 10 seconds;
10% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1602-26) at 1/1,000 dilution was used in 5% NFDM/TBST at room temperature for 2 hours. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1:100,000 dilution was used for 1 hour at room temperature. -
☑ Knockdown (KD)
Western blot analysis of p38 alpha / MAPK14 on different lysates with Rabbit anti-p38 alpha / MAPK14 antibody (ET1602-26) at 1/2,000 dilution.
Lane 1: A549-WT cell lysate
Lane 2: A549-KD p38 alpha / MAPK14 cell lysate
Lysates/proteins at 10 µg/Lane.
Predicted band size: 41 kDa
Observed band size: 38 kDa
Exposure time: 3 minutes; ECL: K1801;
4-20% SDS-PAGE gel.
Proteins were transferred to a PVDF membrane and blocked with 5% NFDM/TBST for 1 hour at room temperature. The primary antibody (ET1602-26) at 1/2,000 dilution was used in 5% NFDM/TBST at 4℃ overnight. Goat Anti-Rabbit IgG - HRP Secondary Antibody (HA1001) at 1/50,000 dilution was used for 1 hour at room temperature. -
☑ Cell treatment (CT)
Immunocytochemistry analysis of HeLa cells treated with UV for 30 minutes then recover 30 minutes labeling p38 alpha / MAPK14 with Rabbit anti-p38 alpha / MAPK14 antibody (ET1602-26) at 1/500 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-p38 alpha / MAPK14 antibody (ET1602-26) at 1/500 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of RAW264.7 cells labeling p38 alpha / MAPK14 with Rabbit anti-p38 alpha / MAPK14 antibody (ET1602-26) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-p38 alpha / MAPK14 antibody (ET1602-26) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Immunocytochemistry analysis of C6 cells labeling p38 alpha / MAPK14 with Rabbit anti-p38 alpha / MAPK14 antibody (ET1602-26) at 1/100 dilution.
Cells were fixed in 4% paraformaldehyde for 20 minutes at room temperature, permeabilized with 0.1% Triton X-100 in PBS for 5 minutes at room temperature, then blocked with 1% BSA in 10% negative goat serum for 1 hour at room temperature. Cells were then incubated with Rabbit anti-p38 alpha / MAPK14 antibody (ET1602-26) at 1/100 dilution in 1% BSA in PBST overnight at 4 ℃. Goat Anti-Rabbit IgG H&L (iFluor™ 488, HA1121) was used as the secondary antibody at 1/1,000 dilution. PBS instead of the primary antibody was used as the secondary antibody only control. Nuclear DNA was labelled in blue with DAPI.
Beta tubulin (M1305-2, red) was stained at 1/100 dilution overnight at +4℃. Goat Anti-Mouse IgG H&L (iFluor™ 594, HA1126) was used as the secondary antibody at 1/1,000 dilution. -
Flow cytometric analysis of HeLa cells labeling p38 alpha / MAPK14.
Cells were fixed and permeabilized. Then stained with the primary antibody (ET1602-26, 1/1,000) (red) compared with Rabbit IgG Isotype Control (green). After incubation of the primary antibody at +4℃ for an hour, the cells were stained with a iFluor™ 488 conjugate-Goat anti-Rabbit IgG Secondary antibody (HA1121) at 1/1,000 dilution for 30 minutes at +4℃. Unlabelled sample was used as a control (cells without incubation with primary antibody; black).
Please note: All products are "FOR RESEARCH USE ONLY AND ARE NOT INTENDED FOR DIAGNOSTIC OR THERAPEUTIC USE"
Citation
-
Kaempferol in a Complex Formula Protects Heart from Jellyfish Venom by Modulating MAPK Signaling
Journal: Toxicon
DOI: 10.1016/j.toxicon.2026.109083
IF: 2.4
Application: WB
Reactivity: Rat
Publish date: 2026 Mar
-
Synergistic therapy for diabetic retinopathy via dual blockade of VEGF-A and TNF-α with a bispecific nanobody
Journal: Frontiers In Pharmacology
DOI: 10.3389/fphar.2025.1729606
IF: 4.8
Application: IF-cell
Reactivity: Human
Publish date: 2026 Jan
-
Histone modification-regulated LncRNA DLEU1 interacts with ASCC2/ALKBH3 complex to drive DNA repair, antioxidant homeostasis and glucose metabolism in gastric cancer
Journal: Biomarker Research
DOI: 10.1186/s40364-025-00867-y
IF: 11.5
Application: IF-cell
Reactivity: Human
Publish date: 2026 Jan
-
Tryptanthrin alleviate lung fibrosis via suppression of MAPK/NF-κB and TGF-β1/SMAD signaling pathways in vitro and in vivo
Journal: Toxicology And Applied Pharmacology
DOI: 10.1016/j.taap.2025.117285
IF: 3.3
Application: WB
Reactivity: Mouse
Publish date: 2025 Mar
-
Downregulation of miR-27a-3p induces endothelial injury and senescence and its significance in the development of coronary heart disease
Journal: Cellular Signalling
DOI: 10.1016/j.cellsig.2025.111759
IF: 4.4
Application: WB
Reactivity: Human
Publish date: 2025 Mar
-
Ginsenoside Ro ameliorates cognitive impairment and neuroinflammation in APP/PS1 mice via the IBA1/GFAP-MAPK signaling pathway
Journal: Frontiers In Pharmacology
DOI: 10.3389/fphar.2025.1528590
IF: 4.4
Application: WB
Reactivity: Mouse
Publish date: 2025 Feb
-
Identification and Experimental Validation of OS-Related Gene Sets Based on Integrated Analysis of Single-Cell and Bulk RNA Sequencing Data with Machine Learning in Patients with Sepsis
Journal: Inflammation
DOI: 10.1007/s10753-025-02346-w
IF: 5
Application: WB
Reactivity: Mouse
Publish date: 2025 Aug
-
The CD163/TWEAK/Fn14 axis: A potential therapeutic target for alleviating inflammatory bone loss
Journal: Journal Of Orthopaedic Translation
DOI:
IF: 5.9
Application: WB
Reactivity: Mouse
Publish date: 2024 Oct
-
CD147‐K148me2‐Driven Tumor Cell‐Macrophage Crosstalk Provokes NSCLC Immunosuppression via the CCL5/CCR5 Axis
Journal: Advanced Science
DOI:
IF: 15.1
Application: WB
Reactivity: Human
Publish date: 2024 Jun
-
Targeting DAD1 gene with CRISPR-Cas9 system transmucosally delivered by fluorinated polylysine nanoparticles for bladder cancer intravesical gene therapy
Journal: Theranostics
DOI: 10.7150/thno.88550
IF: 12.4
Application: WB
Reactivity: Human
Publish date: 2024 Jan
-
Scutellarin ameliorates diabetic nephropathy via TGF-β1 signaling pathway
Journal: Biological & Pharmaceutical Bulletin
DOI:
IF: 2.0
Application: WB
Reactivity: Mouse
Publish date: 2023 Oct
-
mTOR signaling pathway regulates embryonic development and rapid growth of triploid crucian carp
Journal: Aquaculture Reports
DOI: 10.1016/j.aqrep.2023.101860
IF: 3.7
Application: WB
Reactivity: Mouse
Publish date: 2023 Nov
-
Apigenin Inhibits the Progression of Osteoarthritis by Mediating Macrophage Polarization
Journal: Molecules
DOI:
IF: 4.927
Application: WB
Reactivity: Mouse
Publish date: 2023 Mar
-
Artesunate alleviates 5-fluorouracil-induced intestinal damage by suppressing cellular senescence and enhances its antitumor activity
Journal: Discover Oncology
DOI:
IF: 2.2
Application: WB
Reactivity: Mouse
Publish date: 2023 Jul
-
EYE-503: A Novel Retinoic Acid Drug for Treating Retinal Neurodegeneration
Journal: Pharmaceuticals
DOI:
IF: 4.6
Application: WB
Reactivity: Mouse
Publish date: 2023 Jul
-
Analyses of Transcriptomics upon IL-1β-Stimulated Mouse Chondrocytes and the Protective Effect of Catalpol through the NOD2/NF-κB/MAPK Signaling Pathway
Journal: Molecules
DOI:
IF: 4.927
Application: WB
Reactivity: Mouse
Publish date: 2023 Feb
-
Maternal consumption of a fermented diet protects offspring against intestinal inflammation by regulating the gut microbiota
Journal: Gut Microbes
DOI:
IF: 10.245
Application: WB
Reactivity: Pig
Publish date: 2022 May
-
Single-Cell Sequencing Yields Insights in the Evolution of Foot-and-Mouth Disease Virus Persistent Infection
Journal: Frontiers In Cellular And Infection Microbiology
DOI:
IF: 6.073
Application: WB
Reactivity: Hamster
Publish date: 2022 Jul
-
CircRFWD2 Promotes Osteogenic Differentiation of human Dental Pulp Stem Cells by Targeting miR-6817-5p Through BMP-Smad and p38 MAPK Pathway
Journal: Cell Transplantation
DOI:
IF: 4.061
Application: WB
Reactivity: Human
Publish date: 2021 Oct
-
CALR-TLR4 Complex Inhibits Non-Small Cell Lung Cancer Progression by Regulating the Migration and Maturation of Dendritic Cells
Journal: Frontiers In Oncology
DOI:
IF: 6.243
Application: WB
Reactivity: Mouse
Publish date: 2021 Oct
-
Optineurin modulates the maturation of dendritic cells to regulate autoimmunity through JAK2-STAT3 signaling
Journal: Nature Communications
DOI:
IF: 14.914
Application: WB
Reactivity: Mouse
Publish date: 2021 Oct
-
miR-20a-5p contributes to osteogenic differentiation of human dental pulp stem cells by regulating BAMBI and activating the phosphorylation of Smad5 and p38
Journal: Stem Cell Research & Therapy
DOI:
IF: 6.832
Application: WB
Reactivity: Human
Publish date: 2021 Nov
-
The N6-methyladenosine RNA-binding protein YTHDF1 modulates the translation of TRAF6 to mediate the intestinal immune response. Nucleic acids research, 49(10), 5537–5552.
Journal: Nucleic Acids Research
DOI:
IF: 16.971
Application:
Reactivity: Mouse
Publish date: 2021 Jun
-
Exopolysaccharide from Cryptococcus heimaeyensis S20 induces autophagic cell death in non-small cell lung cancer cells via ROS/p38 and ROS/ERK signalling
Journal: Cell Proliferation
DOI:
IF: 5.753
Application: WB
Reactivity: Human
Publish date: 2020 Aug
-
Purification of recombinant human fibroblast growth factor 13 in E. coli and its molecular mechanism of mitogenesis
Journal: Applied Microbiology And Biotechnology
DOI:
IF: 3.67
Application: WB
Reactivity: Mouse
Publish date: 2019 Sep
-
Sini decoction ameliorates sepsis-induced acute lung injury via regulating ACE2-Ang (1-7)-Mas axis and inhibiting the MAPK signaling pathway
Journal: Biomedicine & Pharmacotherapy
DOI:
IF: 3.457
Application: WB
Reactivity: Human
Publish date: 2019 Jul
-
Hypo-phosphorylated CD147 promotes migration and invasion of hepatocellular carcinoma cells and predicts a poor prognosis. Cellular oncology (Dordrecht), 42(4), 537–554.
Journal: Cellular Oncology
DOI:
IF: 5.02
Application: WB,Co-IP,IHC-P
Reactivity: Human
Publish date: 2019 Aug
Products with the same target and pathway
p38 alpha / MAPK14 Rabbit Polyclonal Antibody
Application: WB,IF-Cell,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
p38 alpha / MAPK14 Mouse Monoclonal Antibody [9-B9]
Application: WB,IF-Cell,IHC-P,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
p38 alpha / MAPK14 Recombinant Rabbit Monoclonal Antibody [SR43-04] - BSA and Azide free
Application: WB,IF-Cell,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated
p38 alpha / MAPK14 Recombinant Rabbit Monoclonal Antibody [JF55-07]
Application: WB,IF-Cell,IF-Tissue,FC
Reactivity: Human,Mouse,Rat
Conjugate: unconjugated